These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17697148)

  • 1. Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate.
    Mirshahpanah P; Döcke WD; Merbold U; Asadullah K; Röse L; Schäcke H; Zollner TM
    Exp Dermatol; 2007 Sep; 16(9):753-61. PubMed ID: 17697148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.
    Kecskés A; Heger-Mahn D; Kuhlmann RK; Lange L
    J Am Acad Dermatol; 1993 Oct; 29(4):576-80. PubMed ID: 8408793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone.
    Hoffmann K; Auer T; Stücker M; Hoffmann A; Altmeyer P
    J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):137-42. PubMed ID: 9553910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic index makes easier the choice of admissible substances. No fear concerning cortisone].
    MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587199
    [No Abstract]   [Full Text] [Related]  

  • 5. Mometasone versus betamethasone creams: a trial in dermatoses.
    Wishart JM; Lee IS
    N Z Med J; 1993 May; 106(956):203-5. PubMed ID: 8341439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
    Kerscher MJ; Hart H; Korting HC; Stalleicken D
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus.
    Gradman J; Wolthers OD
    Acta Paediatr; 2007 Aug; 96(8):1233-7. PubMed ID: 17590198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
    Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; Worm M; Arcangeli F
    Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical mometasone furoate for vulvar lichen sclerosus.
    Cattaneo A; De Magnis A; Botti E; Sonni L; Carli P; Taddei GL
    J Reprod Med; 2003 Jun; 48(6):444-8. PubMed ID: 12856516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple corticosteroid allergies.
    Chow ET
    Australas J Dermatol; 2001 Feb; 42(1):62-3. PubMed ID: 11233727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mometasone furoate ointment 0.1% vs. hydrocortisone ointment 1.0% in psoriasis. Atrophogenic potential.
    Katz HI; Prawer SE; Watson MJ; Scull TA; Peets EA
    Int J Dermatol; 1989 Jun; 28(5):342-4. PubMed ID: 2753592
    [No Abstract]   [Full Text] [Related]  

  • 12. Shortened treatment duration of glucocorticoid-induced skin atrophy in rats.
    Schoepe S; Vonk R; Schäcke H; Zollner TM; Asadullah K; Röse L
    Exp Dermatol; 2011 Oct; 20(10):853-5. PubMed ID: 21824195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of local anti-inflammatory effect and systemic effects of mometasone furoate in mice.
    Ogawa M; Sakonjo H; Kamei C
    Immunopharmacol Immunotoxicol; 2009; 31(4):601-6. PubMed ID: 19874229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
    Prakash A; Benfield P
    Drugs; 1998 Jan; 55(1):145-63. PubMed ID: 9463794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylprednisolone aceponate in eczema and other inflammatory skin disorders -- a clinical update.
    Ruzicka T
    Int J Clin Pract; 2006 Jan; 60(1):85-92. PubMed ID: 16409433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate.
    Luger TA
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):251-8. PubMed ID: 21294777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.
    Koo J; Cuffie CA; Tanner DJ; Bressinck R; Cornell RC; DeVillez RL; Edwards L; Breneman DL; Piacquadio DJ; Guzzo CA; Monroe EW
    Clin Ther; 1998; 20(2):283-91. PubMed ID: 9589819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
    Tiplica GS; Salavastru CM
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mometasone furoate microemulsion in the treatment of erosive-ulcerative oral lichen planus: pilot study.
    Aguirre JM; Bagán JV; Rodriguez C; Jimenez Y; Martínez-Conde R; Díaz de Rojas F; Ponte A
    J Oral Pathol Med; 2004 Aug; 33(7):381-5. PubMed ID: 15250828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effects of topical mometasone furoate and tacrolimus on skin prick testing in children.
    Gradman J; Wolthers OD
    Pediatr Dermatol; 2008; 25(2):269-70. PubMed ID: 18429800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.